KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming-Reference-Cited by-同舟云学术

KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming

Published:2023-07-19 Issue:7971 Volume:619 Page:860-867
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Juul Nicholas H.,Yoon Jung-Ki^ORCID,Martinez Marina C.,Rishi Neha,Kazadaeva Yana I.,Morri Maurizio,Neff Norma F.,Trope Winston L.,Shrager Joseph B.^ORCID,Sinha Rahul^ORCID,Desai Tushar J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-023-06324-w.pdf

Reference62 articles.

1. Desai, T. J., Brownfield, D. G. & Krasnow, M. A. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 507, 190–194 (2014).

2. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).

3. Desai, T. J. Developmental insights into lung cancer. Annu. Rev. Cancer Biol. 5, 351–369 (2021).

4. Logan, C. Y. & Desai, T. J. Keeping it together: pulmonary alveoli are maintained by a hierarchy of cellular programs. Bioessays 37, 1028–1037 (2015).

5. Lin, C. et al. Alveolar type II cells possess the capability of initiating lung tumor development. PLoS ONE 7, e53817 (2012).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer;Frontiers in Oncology;2024-09-13

2. AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy;Frontiers in Immunology;2024-08-21

3. Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma;2024-06-23

4. Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation;Cancer Letters;2024-06

5. A developmental constraint model of cancer cell states and tumor heterogeneity;Cell;2024-06